← FDA Drug Approvals (Drugs@FDA)
BRENZAVVY
NDA · New Drug Application · Sponsor: THERACOSBIO · Approved 2023-01-20
Drug application
- FDA Application #
NDA214373- Application type
- New Drug Application
- Brand name
- BRENZAVVY
- Generic name
- BEXAGLIFLOZIN
- Active ingredients
- BEXAGLIFLOZIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- THERACOSBIO
- Manufacturer
- TheracosBio, LLC
- First approval
- 2023-01-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown